Voyager Therapeutics首席财务官辞职; Robin Swartz承担财务责任

2026-04-22 04:56

Voyager Therapeutics (VYGR) announced on Tuesday in an SEC Form 8-K filing that its CFO, Nathan Jorgensen, has resigned, effective May 8, 2026, to take up a new opportunity.
The Board has appointed Robin Swartz (current COO & CBO) as the new Principal Financial Officer and Treasurer, effective immediately upon transition, ensuring continuity in finance leadership.
Adding to the leadership reshuffle, Amy Quinlan has been named Principal Accounting Officer, strengthening the company’s accounting oversight.
Following the news, the stock closed ~2.60% lower at ~$4.12.

More on Voyager Therapeutics